Company Website

Contact Information:

Elise Rosenthal
Phone: 480-205-2121
Elise.rosenthal@springworkstx.com

Craig Paulsen
Phone: 952-270-2494
Craig.paulsen@springworkstx.com

Virtual Exhibit Hall Home
 

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer.

Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers. SpringWorks’ gamma secretase inhibitor is the first FDA-approved therapy in the United States for the treatment of adult patients with progressing desmoid tumors who require systemic treatment.

For more information, visit www.springworkstx.com.